HNRNPA2B1 and hepatocellular carcinoma: For example, Linc01232/hnRNPA2B1 promotes pancreatic cancer metastasis via regulating the alternative splicing of A-Raf [11], miR503HG/hnRNPA2B1 inhibits hepatocellular carcinoma progression by reducing the stability of p52 and p65 mRNA [12], and NEAT1/hnRNPA2B1 facilitates fatty acid metabolism through increasing RPRD1B mRNA stability in gastric cancer [13].